Clever Leaves (CLVR) Stock Price, News & Analysis

Company Overview

Clever Leaves, Inc. (NASDAQ: CLVR) is a vertically integrated cannabis company specializing in the cultivation, extraction and distribution of pharmaceutical-grade medical cannabis. With production facilities strategically located in Colombia and Portugal, the company leverages favorable climates and stringent Good Manufacturing Practice (GMP) standards to produce a range of cannabinoid formulations for global markets. Its product portfolio includes dried flower, purified cannabinoids and custom formulations designed to meet regulatory requirements in key jurisdictions.

Originally founded in 2019, Clever Leaves completed a business combination with a special purpose acquisition company in 2021, resulting in its Nasdaq listing. Since then, the company has scaled its operations through the development of advanced cultivation technologies, tissue-culture propagation techniques and a state-of-the-art extraction facility in Portugal. Clever Leaves is focused on quality assurance, analytical testing and traceability protocols to support its mission of providing consistent, research-driven cannabis products.

Clever Leaves serves diverse markets across Europe, Latin America and Canada, supplying medical cannabis to patients and pharmaceutical partners. The company holds cultivation, manufacturing and distribution licenses in Colombia and Portugal, and it actively pursues product registrations and import approvals in regulated jurisdictions. Through collaborations with local clinical research organizations and strategic off-take agreements, Clever Leaves is working to expand patient access to cannabinoid-based therapies.

Guided by an experienced management team with backgrounds in agriculture, pharmaceutical manufacturing and international distribution, Clever Leaves seeks to establish itself as a global leader in the cannabis industry. By combining best-in-class cultivation practices, quality compliance and scientific research, the company aims to deliver scalable solutions that address evolving patient needs and regulatory landscapes.

Key Stats

• Today's Range: $0.0004 to $0.0004
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $1.00
• Volume: 37 shs
• Average Volume: 1,372 shs
• Market Capitalization: $702.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLVR Stock Analysis - Frequently Asked Questions

How have CLVR shares performed this year?

Clever Leaves' stock was trading at $0.0002 at the beginning of 2025. Since then, CLVR shares have increased by 100.0% and is now trading at $0.0004.

When did Clever Leaves' stock split?

Clever Leaves's stock reverse split on Friday, August 25th 2023.The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Clever Leaves?

Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Clever Leaves own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Clever Leaves investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Advanced Micro Devices (AMD) and Salesforce (CRM).

Company Calendar

• Today: 9/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CLVR
• CIK: 1819615
• Web: www.cleverleaves.com
• Phone: 561-634-7430
• Fax: N/A
• Employees: 560
• Year Founded: 2016

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $17.42 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.02 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 1,755,000
• Free Float: 1,611,000
• Market Cap: $702.00
• Optionable: No Data
• Beta: 3,696.52